Search | IOVS | ARVO Journals

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Complement Dysregulation is Evidenced in iPSC-derived RPE Cells from Stargardt Disease patients

Jane Hu; Nermin Kady; Ashley Macabasco; Michael B Gorin; Anna Matynia; Roxana A Radu

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1507. doi:

ARVO Annual Meeting Abstract July 2019

Reduced expression of “normal” ABCA4 alleles in iPS-derived RPE cells from Stargardt Disease patients

Anna Matynia; Saravanan Karumbayaram; Samuel Strom; Jane Hu; Nermin Kady; Roxana A Radu; Michael B Gorin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):388. doi:

ARVO Annual Meeting Abstract July 2019

Retinoid recycling is impaired in Stargardt iPSC-derived RPE

Roxana A Radu; Nermin Kady; Jane Hu; Jacqueline Pei; Marcia Lloyd; Dean Bok; Michael B Gorin; Saravanan Karumbayaram; Anna Matynia

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2343. doi:

ARVO Annual Meeting Abstract July 2018

Very long chain ceramides production mediated by ELOVL4 stabilizes tight junctions and prevents diabetes-induced retinal vascular permeability

Julia V Busik; Nermin Kady; Xuwen Liu; Todd Lydic; Sergey S Seregin; Andrea Amalfitano; Vince A Chiodo; Sanford L Boye; William W Hauswirth; David A Antonetti

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3002. doi:

ARVO Annual Meeting Abstract July 2018

Characterization of Stargardt iPSC-derived RPE cells

Nermin Kady; Anna Matynia; Saravanan Karumbayaram; Jane Hu; Marcia Lloyd; Dean Bok; Michael B Gorin; Roxana A. Radu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3045. doi:

ARVO Annual Meeting Abstract June 2017

Overexpression of ELOVL4 stabilizes tight junctions and prevents VEGF-induced vascular permeability in diabetic retina and retinal cells.

Nermin Kady; Xuwen Liu; Todd Lydic; Segey Seregin; Andrea Amalfitano; Vince A Chiodo; Sanford L Boye; William Hauswirth; Maria B Grant; David Antonetti; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4034. doi:

ARVO Annual Meeting Abstract September 2016

Targeting Acid Sphingomyelinase and Vascular Endothelial Growth Factor by miR-15a to Treat Diabetic Retinopathy

Julia V Busik; Svetlana N Navitskaya; Harshini Chakravarthy; Chao Huang; Nermin Kady; Todd V Lydic; Walter V Esselman; Maria B Grant; Qi Wang

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2723. doi:

ARVO Annual Meeting Abstract September 2016

The Role Of Acid Sphingomyelinase In Shifting The Balance Between Pro-inflammatory And Reparative Bone Marrow Cells In Diabetic Retinopathy

Walter V Esselman; Harshini Chakravarthy; Svetlana N Navitskaya; Sandra V O'Reilly; Eleni Beli; Qi Wang; Nermin Kady; Chao Huang; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3203. doi:

ARVO Annual Meeting Abstract June 2015

Overexpression of hELOVL4 prevents diabetes-induced blood-retinal barrier breakdown through an increase in very long chain ceramides

Nermin Kady; Xuwen Liu; Todd Lydic; Sergey Seregin; Andrea Amalfitano; Vince Chiodo; Sanford L Boye; William W Hauswirth; David A Antonetti; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4292. doi:

ARVO Annual Meeting Abstract April 2014

Spleen as the source of infiltrating monocytes in the diabetic retina

Eleni Beli; Svetlana Bozack; Harshini Chakravarthy; Qi Wang; Nermin Kady; Tatiana Salazar; James M Dominguez; Ashay D Bhatwadekar; Maria Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4907. doi:

Advertisement